Overview
Drug-induced pneumonitis is a hypersensitivity reaction characterized by inflammation of lung parenchyma triggered by certain medications, leading to symptoms such as cough, dyspnea, and pulmonary infiltrates on imaging. 1Diagnosis
Clinical suspicion based on temporal relationship between drug exposure and onset of symptoms.
Radiographic findings: bilateral interstitial or alveolar infiltrates on chest X-ray or CT scan.
Laboratory tests: may show elevated inflammatory markers (e.g., ESR, CRP).
Bronchoalveolar lavage (BAL) and lung biopsy in severe cases to rule out other causes.
Grading systems often not specified; clinical severity guides management decisions. 1Management
Drug cessation: Immediate discontinuation of the suspected drug. 1
Supportive care: Oxygen therapy for hypoxemia, mechanical ventilation if respiratory failure occurs.
Corticosteroids: High-dose glucocorticoids (e.g., prednisone 40-60 mg/day) for severe cases to reduce inflammation. 1
Monitoring: Close observation for clinical improvement and complications.
Adjunctive treatments: Immunosuppressive agents (e.g., cyclophosphamide) considered in refractory cases, though specific dosing not detailed here. 1Special Populations
No specific data: The provided abstract does not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities. 1Key Recommendations
Discontinue the suspected drug immediately upon suspicion of drug-induced pneumonitis (Evidence: Expert opinion 1).
Initiate high-dose corticosteroids for management of moderate to severe cases (Evidence: Weak 1).
Monitor patients closely for clinical improvement and adjust supportive care as needed (Evidence: Expert opinion 1).References
1 Markou N, Antzoulatos N, Haniotou A, Kanakaki M, Parissis J, Damianos A. A case of drug-induced pneumonitis caused by carvedilol. Respiration; international review of thoracic diseases 2004. link